Yosef Refaeli - Publications

Affiliations: 
University of Colorado Anschutz Medical Campus, Denver, Aurora, CO 
Area:
Cell Biology, Physiology Biology

39 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Pennell CA, Campbell H, Storlie MD, Bolivar-Wagers S, Osborn MJ, Refaeli Y, Jensen M, Viaud S, Young TS, Blazar BR. Human CD19-specific switchable CAR T-cells are efficacious as constitutively active CAR T-cells but cause less morbidity in a mouse model of human CD19 malignancy. Journal For Immunotherapy of Cancer. 10. PMID 36521930 DOI: 10.1136/jitc-2022-005934  0.499
2020 Thangavelu G, Wang C, Loschi M, Saha A, Osborn M, Furlan SN, Aoyama K, McDonald-Hyman C, Aguilar EG, Janesick AS, Chandraratna RA, Refaeli Y, Panoskaltsis-Mortari A, MacDonald KP, Hill GR, et al. Repurposing a novel anti-cancer RXR agonist to attenuate acute GVHD and maintain graft-versus-leukemia responses. Blood. PMID 32976550 DOI: 10.1182/blood.2020005628  0.393
2019 Saha A, Taylor PA, Lees CJ, Panoskaltsis-Mortari A, Osborn MJ, Feser CJ, Thangavelu G, Melchinger W, Refaeli Y, Hill GR, Munn DH, Murphy WJ, Serody JS, Maillard I, Kreymborg K, et al. Donor and host B7-H4 expression negatively regulates acute graft-versus-host disease lethality. Jci Insight. 4. PMID 31578305 DOI: 10.1172/Jci.Insight.127716  0.425
2018 Pennell CA, Barnum JL, McDonald-Hyman CS, Panoskaltsis-Mortari A, Riddle MJ, Xiong Z, Loschi M, Thangavelu G, Campbell HM, Storlie MD, Refaeli Y, Furlan SN, Jensen MC, Kean LS, Miller JS, et al. Human CD19-Targeted Mouse T Cells Induce B Cell Aplasia and Toxicity in Human CD19 Transgenic Mice. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 29735365 DOI: 10.1016/J.Ymthe.2018.04.006  0.57
2017 Jacobs L, Habringer S, Slawska J, Huber K, Hauf E, Li Z, Refaeli Y, Schwaiger M, Rudelius M, Walch A, Keller U. Functional imaging in combination with mutation status aids prediction of response to inhibiting B-cell receptor signaling in lymphoma. Oncotarget. 8: 78917-78929. PMID 29108275 DOI: 10.18632/Oncotarget.20551  0.357
2016 Morton JJ, Bird G, Refaeli Y, Jimeno A. Humanized mouse xenograft models: narrowing the tumor-microenvironment gap. Cancer Research. PMID 27587540 DOI: 10.1158/0008-5472.Can-16-1260  0.365
2015 Morton JJ, Bird G, Keysar SB, Astling DP, Lyons TR, Anderson RT, Glogowska MJ, Estes P, Eagles JR, Le PN, Gan G, McGettigan B, Fernandez P, Padilla-Just N, Varella-Garcia M, ... ... Refaeli Y, et al. XactMice: humanizing mouse bone marrow enables microenvironment reconstitution in a patient-derived xenograft model of head and neck cancer. Oncogene. PMID 25893296 DOI: 10.1038/Onc.2015.94  0.457
2014 Bird GA, Polsky A, Estes P, Hanlon T, Hamilton H, Morton JJ, Gutman J, Jimeno A, Turner BC, Refaeli Y. Expansion of human and murine hematopoietic stem and progenitor cells ex vivo without genetic modification using MYC and Bcl-2 fusion proteins. Plos One. 9: e105525. PMID 25170611 DOI: 10.1371/Journal.Pone.0105525  0.386
2012 Bjordahl RL, Gapin L, Marrack P, Refaeli Y. iNKT cells suppress the CD8+ T cell response to a murine Burkitt's-like B cell lymphoma. Plos One. 7: e42635. PMID 22880059 DOI: 10.1371/Journal.Pone.0042635  0.611
2012 Refaeli Y, Van Parijs L, Alexander SI, Abbas AK. Interferon γ is required for activation-induced death of T lymphocytes The Journal of Experimental Medicine. 209: 1049-1049. DOI: 10.1084/Jem.200206662095C  0.457
2009 Young RM, Polsky A, Refaeli Y. TC-PTP is required for the maintenance of MYC-driven B-cell lymphomas. Blood. 114: 5016-23. PMID 19755676 DOI: 10.1182/Blood-2008-12-196709  0.545
2009 Refaeli Y, Bhoumik A, Roop DR, Ronai ZA. Melanoma-initiating cells: a compass needed. Embo Reports. 10: 965-72. PMID 19680286 DOI: 10.1038/Embor.2009.184  0.402
2009 Clarke RL, Thiemann S, Refaeli Y, Werlen G, Potter TA. A new function for LAT and CD8 during CD8-mediated apoptosis that is independent of TCR signal transduction. European Journal of Immunology. 39: 1619-31. PMID 19449311 DOI: 10.1002/Eji.200839062  0.352
2009 Van Parijs L, Refaeli Y, Lord JD, Nelson BH, Abbas AK, Baltimore D. Retraction. Uncoupling IL-2 signals that regulate T cell proliferation, survival, and Fas-mediated activation-induced cell death. Immunity. 30: 611. PMID 19382300 DOI: 10.1016/j.immuni.2009.04.002  0.351
2009 Van Parijs L, Refaeli Y, Abbas AK, Baltimore D. Retraction. Autoimmunity as a consequence of retrovirus-mediated expression of C-FLIP in lymphocytes. Immunity. 30: 612. PMID 19378495 DOI: 10.1016/J.Immuni.2009.04.003  0.411
2009 Zemans RL, Briones N, Young SK, Malcolm KC, Refaeli Y, Downey GP, Worthen GS. A novel method for long term bone marrow culture and genetic modification of murine neutrophils via retroviral transduction. Journal of Immunological Methods. 340: 102-15. PMID 19010330 DOI: 10.1016/J.Jim.2008.10.004  0.328
2009 Young RM, Hardy IR, Clarke RL, Lundy N, Pine P, Turner BC, Potter TA, Refaeli Y. Mouse models of non-Hodgkin lymphoma reveal Syk as an important therapeutic target. Blood. 113: 2508-16. PMID 18981293 DOI: 10.1182/Blood-2008-05-158618  0.497
2008 Young RM, Turner BC, Refaeli Y. B-cell receptor signaling in the genesis and maintenance of B-cell lymphoma. Future Oncology (London, England). 4: 591-4. PMID 18922114 DOI: 10.2217/14796694.4.5.591  0.543
2008 Refaeli Y, Young RM, Turner BC, Duda J, Field KA, Bishop JM. The B cell antigen receptor and overexpression of MYC can cooperate in the genesis of B cell lymphomas. Plos Biology. 6: e152. PMID 18578569 DOI: 10.1371/Journal.Pbio.0060152  0.503
2008 Field KA, Charoenthongtrakul S, Bishop JM, Refaeli Y. Farnesyl transferase inhibitors induce extended remissions in transgenic mice with mature B cell lymphomas. Molecular Cancer. 7: 39. PMID 18489761 DOI: 10.1186/1476-4598-7-39  0.515
2008 Jin L, Stolpa JC, Young RM, Pugh-Bernard AE, Refaeli Y, Cambier JC. MHC class II structural requirements for the association with Igalpha/beta, and signaling of calcium mobilization and cell death. Immunology Letters. 116: 184-94. PMID 18194817 DOI: 10.1016/J.Imlet.2007.11.023  0.362
2008 Turner BC, Eves T, Refaeli Y. Small-molecule inhibitors of Bcl-2 family proteins are able to induce tumor regression in a mouse model of pre-B-cell acute lymphocytic lymphoma. Dna and Cell Biology. 27: 133-42. PMID 18163880 DOI: 10.1089/Dna.2007.0675  0.543
2007 Chu HW, Thaikoottathil J, Rino JG, Zhang G, Wu Q, Moss T, Refaeli Y, Bowler R, Wenzel SE, Chen Z, Zdunek J, Breed R, Young R, Allaire E, Martin RJ. Function and regulation of SPLUNC1 protein in Mycoplasma infection and allergic inflammation. Journal of Immunology (Baltimore, Md. : 1950). 179: 3995-4002. PMID 17785838 DOI: 10.4049/Jimmunol.179.6.3995  0.331
2007 Jorgensen TN, McKee A, Wang M, Kushnir E, White J, Refaeli Y, Kappler JW, Marrack P. Bim and Bcl-2 mutually affect the expression of the other in T cells. Journal of Immunology (Baltimore, Md. : 1950). 179: 3417-24. PMID 17785775 DOI: 10.4049/Jimmunol.179.6.3417  0.398
2005 Refaeli Y, Field KA, Turner BC, Trumpp A, Bishop JM. The protooncogene MYC can break B cell tolerance. Proceedings of the National Academy of Sciences of the United States of America. 102: 4097-102. PMID 15753301 DOI: 10.1073/Pnas.0409832102  0.546
2002 Refaeli Y, Van Parijs L, Alexander SI, Abbas AK. Interferon gamma is required for activation-induced death of T lymphocytes. The Journal of Experimental Medicine. 196: 999-1005. PMID 12370261 DOI: 10.1084/jem.20020666  0.353
2002 Kelly E, Won A, Refaeli Y, Van Parijs L. IL-2 and related cytokines can promote T cell survival by activating AKT. Journal of Immunology (Baltimore, Md. : 1950). 168: 597-603. PMID 11777951 DOI: 10.4049/Jimmunol.168.2.597  0.436
2001 Trumpp A, Refaeli Y, Oskarsson T, Gasser S, Murphy M, Martin GR, Bishop JM. c-Myc regulates mammalian body size by controlling cell number but not cell size. Nature. 414: 768-73. PMID 11742404 DOI: 10.1038/414768A  0.354
2001 Lois C, Refaeli Y, Qin XF, Van Parijs L. Retroviruses as tools to study the immune system. Current Opinion in Immunology. 13: 496-504. PMID 11498308 DOI: 10.1016/S0952-7915(00)00247-8  0.306
2000 Buchholz F, Refaeli Y, Trumpp A, Bishop JM. Inducible chromosomal translocation of AML1 and ETO genes through Cre/loxP-mediated recombination in the mouse. Embo Reports. 1: 133-9. PMID 11265752 DOI: 10.1093/Embo-Reports/Kvd027  0.384
2000 Dickey C, Ziegner U, Agadjanyan MG, Srikantan V, Refaeli Y, Prabhu A, Sato A, Williams WV, Weiner DB, Ugen KE. Murine monoclonal antibodies biologically active against the amino region of HIV-1 gp120: isolation and characterization. Dna and Cell Biology. 19: 243-52. PMID 10798448 DOI: 10.1089/104454900314519  0.306
1999 Van Parijs L, Refaeli Y, Abbas AK, Baltimore D. Autoimmunity as a consequence of retrovirus-mediated expression of C-FLIP in lymphocytes. Immunity. 11: 763-70. PMID 10626898 DOI: 10.1016/S1074-7613(00)80150-8  0.467
1999 Van Parijs L, Refaeli Y, Lord JD, Nelson BH, Abbas AK, Baltimore D. Uncoupling IL-2 signals that regulate T cell proliferation, survival, and Fas-mediated activation-induced cell death. Immunity. 11: 281-8. PMID 10514006 DOI: 10.1016/S1074-7613(00)80103-X  0.422
1999 Refaeli Y, Van Parijs L, Abbas AK. Genetic models of abnormal apoptosis in lymphocytes. Immunological Reviews. 169: 273-82. PMID 10450524 DOI: 10.1111/J.1600-065X.1999.Tb01322.X  0.39
1998 Refaeli Y, Van Parijs L, London CA, Tschopp J, Abbas AK. Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis. Immunity. 8: 615-23. PMID 9620682 DOI: 10.1016/S1074-7613(00)80566-X  0.431
1995 Levy DN, Refaeli Y, Weiner DB. Extracellular Vpr protein increases cellular permissiveness to human immunodeficiency virus replication and reactivates virus from latency. Journal of Virology. 69: 1243-52. PMID 7815499 DOI: 10.1128/Jvi.69.2.1243-1252.1995  0.378
1995 Levy DN, Refaeli Y, Weiner DB. The vpr regulatory gene of HIV. Current Topics in Microbiology and Immunology. 193: 209-36. PMID 7648876 DOI: 10.1007/978-3-642-78929-8_11  0.315
1994 Levy DN, Refaeli Y, MacGregor RR, Weiner DB. Serum Vpr regulates productive infection and latency of human immunodeficiency virus type 1. Proceedings of the National Academy of Sciences of the United States of America. 91: 10873-7. PMID 7971975 DOI: 10.1073/Pnas.91.23.10873  0.381
1993 Wang B, Ugen KE, Srikantan V, Agadjanyan MG, Dang K, Refaeli Y, Sato AI, Boyer J, Williams WV, Weiner DB. Gene inoculation generates immune responses against human immunodeficiency virus type 1 Proceedings of the National Academy of Sciences of the United States of America. 90: 4156-4160. PMID 8483929 DOI: 10.1073/Pnas.90.9.4156  0.334
Show low-probability matches.